Detalles de la búsqueda
1.
Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go?
Oncologist
; 29(5): e699-e707, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38127280
2.
Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study.
Lancet Oncol
; 24(12): e461-e471, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37459873
3.
Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial.
Lancet
; 399(10336): 1718-1729, 2022 04 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35367007
4.
Similar local recurrence and survival in patients with T1 radial growth phase melanoma on head and neck treated with 5 or 10 mm margins: A retrospective study.
J Eur Acad Dermatol Venereol
; 37(7): 1318-1326, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36924058
5.
Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting.
Int J Mol Sci
; 24(5)2023 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36901733
6.
Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study.
Lancet Oncol
; 23(9): 1145-1155, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35940183
7.
Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma.
J Transl Med
; 20(1): 159, 2022 04 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35382857
8.
Germline MC1R variants and frequency of somatic BRAF, NRAS, and TERT mutations in melanoma: Literature review and meta-analysis.
Mol Carcinog
; 60(3): 167-171, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33444485
9.
Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access program.
J Transl Med
; 19(1): 70, 2021 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33588870
10.
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort.
J Transl Med
; 19(1): 270, 2021 06 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34167578
11.
Course of Sars-CoV2 Infection in Patients with Cancer Treated with anti-PD-1: A Case Presentation and Review of the Literature.
Cancer Invest
; 39(1): 9-14, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33125301
12.
Treatment beyond progression with anti-PD-1/PD-L1 based regimens in advanced solid tumors: a systematic review.
BMC Cancer
; 21(1): 425, 2021 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33865350
13.
The surgical treatment of non-metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): a retrospective cohort quality improvement study to reduce the morbidity rates.
BMC Cancer
; 21(1): 8, 2021 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33402122
14.
Neuromuscular complications following targeted therapy in cancer patients: beyond the immune checkpoint inhibitors. Case reports and review of the literature.
Neurol Sci
; 42(4): 1405-1409, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32783159
15.
Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations.
J Med Genet
; 57(5): 316-321, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30291219
16.
Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial.
Lancet Oncol
; 21(11): 1465-1477, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32961119
17.
The adjuvant treatment revolution for high-risk melanoma patients.
Semin Cancer Biol
; 59: 283-289, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31445219
18.
Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy.
Semin Cancer Biol
; 59: 290-297, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31430555
19.
HO-1 downregulation favors BRAFV600 melanoma cell death induced by Vemurafenib/PLX4032 and increases NK recognition.
Int J Cancer
; 146(7): 1950-1962, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31376303
20.
Phenotypic characterization of tumor CTLA-4 expression in melanoma tissues and its possible role in clinical response to Ipilimumab.
Clin Immunol
; 215: 108428, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32344017